The 17th International Congress on Infectious Diseases (ICID) is taking place in Hyderabad, India, from March 2-5, 2016. This year DRIVE-AB will be collaborating on a symposium titled, “New and recently approved antibiotics: Challenges and opportunities”. The symposium will take place on Saturday, March 5 in Hall 2 from 10:15 – 12:15hrs and will be co-chaired by R. Rangarajan (India) and DRIVE-AB participant U. Theuretzbacher (Austria).
Another DRIVE-AB participant, C. Årdal (Norway), will be giving a presentation during the symposium on “Incentivising antibiotic innovation“.
New and Recently Approved Antibiotics: Challenges and Opportunities
(in collaboration with DRIVE-AB- a project of the Innovative Medicines Initiative)
Saturday, March 5, 2016, 10:15 – 12:15hrs, Room: Hall 2
Co-chairs: R. Rangarajan (India), U. Theuretzbacher (Austria)
- New Antibiotics: What do we Need?
D. Morgan (USA)
- The Antibiotic Pipeline: What Can we Expect?
U. Theuretzbacher (Austria)
- Incentivizing Antibiotic Innovation
C. Årdal (Norway)
- Sustaining the Clinical Use of Antibiotics
A. Holmes (United Kingdom)
To view the entire 17th ICID program, please click here.
To view Dr Theuretzbacher’s presentation, “The Antibiotic Pipeline: What Can We Expect?”, click here.
To view Dr Årdals’ presentation, “Incentivizing Antibiotic Innovation”, click here.